Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis

Coronavirus disease 2019 (COVID-19) infection has now reached a pandemic state, affecting more than a million patients worldwide. Predictors of disease outcomes in these patients need to be urgently assessed to decrease morbidity and societal burden. Lactate dehydrogenase (LDH) has been associated with worse outcomes in patients with viral infections. In this pooled analysis of 9 published studies (n  = 1532 COVID-19 patients), we evaluated the association between elevated LDH levels measured at earliest time point in hospitalization and disease outcomes in patients with COVID-19.

Source: The American Journal of Emergency Medicine - May 25, 2020 Category: Emergency Medicine Authors: Brandon Michael Henry, Gaurav Aggarwal, Johnny Wong, Stefanie Benoit, Jens Vikse, Mario Plebani, Giuseppe Lippi Source Type: research